Ignacio Duran, Miguel A. Climent Duran, Iciar García Carbonero, Angela Villares, Ricardo Sánchez-Escribano, Jesus Calleja, Naiara Sagastibelza, Ainara Villafruela, Isabel Galante, Jose Luis Dominguez, Albert Font Pous, Pol Servian, Nuria Lainez, Vicente Grasa, Urbano Anido, Anton Cimadevila, Mario Dominguez, Xavier Garcia del Muro, Oscar Buisan, Javier Puente. "Phase 2 study of perioperative sacituzumab govitecan in combination with zimberelimab and domvanalimab for patients with muscle invasive bladder cancer ineligible or who refuse cisplatin-based chemotherapy: The PRISMA-1 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps884